Essex Investment Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Essex Investment Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-400,573	Closed	-$2.21M	–	440
2022 Q3	$2.21M	Buy	400,573 +11,159	+3%	+$61.9K	0.35%	89
2022 Q2	$1.42M	Buy	389,414 +13,161	+3%	+$62.2K	0.23%	127
2022 Q1	$2.28M	Buy	376,253 +17,413	+5%	+$106K	0.28%	108
2021 Q4	$3.02M	Buy	358,840 +116,189	+48%	+$1.02M	0.35%	88
2021 Q3	$2.2M	Sell	242,651 -1,546	-0.6%	-$13.3K	0.27%	119
2021 Q2	$1.98M	Buy	+244,197	New	+$1.68M	0.23%	141

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Essex Investment Management's APEN Position: Q4 2022 in Review

Essex Investment Management sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2022, closing a stake of 400,573 shares — an estimated $2.21M sold.

Essex Investment Management first reported a position in APEN in Q2 2021 and held it in 6 quarters. The position peaked at $3.02M in Q4 2021. 81 funds tracked by Wall St. Rank hold APEN as of Q4 2022.

Essex Investment Management reported no remaining Apollo Endosurgery, Inc. position as of Q4 2022 after selling out during the quarter.
Essex Investment Management sold 400,573 Apollo Endosurgery, Inc. shares in Q4 2022, an estimated $2.21M.
Essex Investment Management first reported a position in Apollo Endosurgery, Inc. in Q2 2021 and held it in 6 quarters.
Essex Investment Management's Apollo Endosurgery, Inc. position peaked at $3.02M in Q4 2021.
81 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2022.

Based on Essex Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.